Instrument Inactif

Communiqués Polydex Pharmaceuticals Limited

Actions

POLXF

BS7317282002

Produits pharmaceutiques

Communiqués

18/07/23	Polydex Pharmaceuticals Limited Shareholders Vote to Approve BioSpectra Inc. Business Combination	AQ
15/06/23	Polydex Pharmaceuticals Issues First Quarter Financial Results	AQ
01/05/23	Polydex Pharmaceuticals Issues Year End Financial Results	AQ
27/04/23	Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business Combination	AQ
15/12/22	Polydex Pharmaceuticals Issues Third Quarter Financial Results	AQ
30/11/22	Polydex Pharmaceuticals : 2023 Third Quarter	PU
15/09/22	Polydex Pharmaceuticals Issues Second Quarter Financial Results	AQ
09/09/22	Polydex Pharmaceuticals : 2023 Second Quarter	PU
15/06/22	Polydex Pharmaceuticals Issues First Quarter Financial Results	AQ
02/05/22	Polydex Pharmaceuticals Issues Year End Financial Results	AQ
02/05/22	Polydex Pharmaceuticals : 2022 Financial Statements	PU
29/04/22	Polydex Pharmaceuticals : 2022 Annual Report	PU
27/01/22	Polydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions For novel use of Native Dextran Patented cooling water treatment reduces the use of harmful chemicals	AQ
26/01/22	Polydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native Dextran	AQ
15/12/21	Polydex Pharmaceuticals Issues Third Quarter Financial Results	AQ
15/12/21	Polydex Pharmaceuticals : October 31 2021 Disclosure Statement	PU
15/12/21	Polydex Pharmaceuticals : October 31 2021 Financial Statements	PU
03/12/21	Polydex Pharmaceuticals : 2022 Third Quarter	PU
15/09/21	Polydex Pharmaceuticals : Issues Second Quarter Financial Results	AQ
15/06/21	Polydex Pharmaceuticals Issues First Quarter Financial Results	GL
30/04/21	Polydex Pharmaceuticals Issues Year End Financial Results	GL
15/12/20	Polydex Pharmaceuticals Issues Third Quarter Financial Results	GL
15/09/20	Polydex Pharmaceuticals Issues Second Quarter Financial Results	GL
15/06/20	Polydex Pharmaceuticals Issues First Quarter Financial Results	GL
30/04/20	Polydex Pharmaceuticals Provides Year End Financial Report Closing the Year With A Strong Cash Position and Low Debt	GL